Zhang Xinyue, Zhu Zhigang, Zhu Liuhui, Guan Ying, Zhu Zhouhai, Liu Bin, Ren Hui, Yang Xinglong
Department of Geriatric Neurology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, PR China.
Joint Institute of Smoking and Health, Kunming, Yunnan Province, PR China.
Nicotine Tob Res. 2025 Apr 22;27(5):884-892. doi: 10.1093/ntr/ntae180.
Smoking (nicotine) has been reported to possibly be neuroprotective and conducive to patients with early Parkinson's disease (PD). However, the causal effect of smoking on PD and the molecular mechanisms of smoking-related genes (SRGs) are vague.
First, genome-wide association study summary data on smoking (ukb-b-6244) and PD (ieu-b-7) were retrieved from the Integrative Epidemiology Unit OpenGWAS database for Mendelian randomization (MR) analysis. Sensitivity analyses were performed to validate the results of the MR analyses. Subsequently, a differential analysis of PD patients and controls was performed to identify differentially expressed SRGs (DE-SRGs). Finally, the expression of DE-SRGs was analyzed in annotated cell types.
The MR analysis revealed that smoking was a protective factor causally related to PD (p = .008, odds ratio = 0.288). Furthermore, a total of five DE-SRGs enriched in Toll-like receptor signaling pathways were identified in GSE7621 dataset. Regarding the single-cell analysis of the GSE184950 dataset, a total of nine cell types were annotated. The expression of LRRN1 in oligodendrocyte progenitor cells and oligodendrocytes, respectively, differed significantly between PD patients and controls.
Our study supported a causal relationship between smoking and PD and found that five SRGs (MAPK8IP1, LRRN1, LINC00324, HIST1H2BK, and YOD1) enriched in Toll-like receptor signaling pathways might be beneficial in PD. In addition, single-cell sequencing indicated that four SRGs were differentially expressed in different cell types. All four genes except MAPK8IP1 were significantly correlated with the 10 genes calculated by scPagwas. Thus, this evidence provides a theoretical basis for further research on the effect of nicotine (smoking) on PD.
In search of explore the potential etiology and pathogenesis of Parkinson's disease, this study combined MR analysis, transcriptomics, and single-cell sequencing analysis to explore the association between exposure factors and Parkinson's disease, observe and confirm the relationship and mechanism between the two from the perspective of genetics, and provide more reliable evidence for causal inference.
据报道,吸烟(尼古丁)可能具有神经保护作用,对早期帕金森病(PD)患者有益。然而,吸烟对PD的因果效应以及吸烟相关基因(SRGs)的分子机制尚不清楚。
首先,从综合流行病学单位开放GWAS数据库中检索吸烟(ukb-b-6244)和PD(ieu-b-7)的全基因组关联研究汇总数据,进行孟德尔随机化(MR)分析。进行敏感性分析以验证MR分析的结果。随后,对PD患者和对照进行差异分析,以鉴定差异表达的SRGs(DE-SRGs)。最后,在注释的细胞类型中分析DE-SRGs的表达。
MR分析显示,吸烟是与PD有因果关系的保护因素(p = 0.008,优势比 = 0.288)。此外,在GSE7621数据集中鉴定出总共5个富集于Toll样受体信号通路的DE-SRGs。关于GSE184950数据集的单细胞分析,总共注释了9种细胞类型。PD患者和对照之间,少突胶质细胞祖细胞和少突胶质细胞中LRRN1的表达分别存在显著差异。
我们的研究支持吸烟与PD之间的因果关系,并发现5个富集于Toll样受体信号通路的SRGs(MAPK8IP1、LRRN1、LINC00324、HIST1H2BK和YOD1)可能对PD有益。此外,单细胞测序表明4个SRGs在不同细胞类型中差异表达。除MAPK8IP1外,所有4个基因均与scPagwas计算的10个基因显著相关。因此,该证据为进一步研究尼古丁(吸烟)对PD的影响提供了理论依据。
为探索帕金森病的潜在病因和发病机制,本研究结合MR分析、转录组学和单细胞测序分析,探讨暴露因素与帕金森病之间的关联,从遗传学角度观察并确认两者之间的关系和机制,为因果推断提供更可靠的证据。